In iPSCs derived from C9orf72 HRE ALS patients, restoring the normal C9orf72 gene by CRISPR/Cas9 restored diminished pathological phenotypes [112]. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.